share_log

Medifast Analyst Ratings

Medifast Analyst Ratings

醫療快分析師評級
Benzinga ·  2023/10/13 16:59
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/13/2023 19.05% Stephens & Co. → $82 Initiates Coverage On → Equal-Weight
08/08/2023 16.14% DA Davidson $93 → $80 Maintains Neutral
07/31/2023 35.02% DA Davidson $75 → $93 Maintains Neutral
05/02/2023 3.08% DA Davidson $94 → $71 Maintains Neutral
02/22/2023 36.47% DA Davidson $106 → $94 Maintains Neutral
11/04/2022 53.89% DA Davidson $278 → $106 Downgrades Buy → Neutral
08/04/2022 303.6% DA Davidson $352 → $278 Maintains Buy
08/04/2022 117.77% Jefferies $345 → $150 Downgrades Buy → Hold
06/02/2022 411.03% DA Davidson $341 → $352 Maintains Buy
02/24/2022 395.06% DA Davidson $349 → $341 Maintains Buy
11/08/2021 406.68% DA Davidson $395 → $349 Maintains Buy
05/05/2021 473.46% DA Davidson $302 → $395 Maintains Buy
02/26/2021 338.44% DA Davidson $239 → $302 Maintains Buy
01/25/2021 284.73% Jefferies $205 → $265 Upgrades Hold → Buy
01/12/2021 246.98% DA Davidson $205 → $239 Maintains Buy
11/05/2020 197.62% DA Davidson $180 → $205 Upgrades Neutral → Buy
06/25/2020 138.1% B. Riley Securities → $164 Initiates Coverage On → Buy
05/06/2020 24.85% DA Davidson $83 → $86 Maintains Neutral
02/27/2020 20.5% DA Davidson $74 → $83 Maintains Neutral
11/08/2019 7.43% DA Davidson $250 → $74 Downgrades Buy → Neutral
07/25/2019 88.73% Jefferies → $130 Initiates Coverage On → Buy
02/27/2019 213.59% Sidoti & Co. $211 → $216 Maintains Buy
11/08/2018 Sidoti & Co. Upgrades Neutral → Buy
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
2023年10月13日 19.05% 斯蒂芬斯公司 →$82 開始承保 →等重
2023/08/08 16.14% 達·戴維森 $93→$80 維護 中性
07/31/2023 35.02% 達·戴維森 $75→$93 維護 中性
05/02/2023 3.08% 達·戴維森 $94→$71 維護 中性
02/22/2023 36.47% 達·戴維森 $106→$94 維護 中性
11/04/2022 53.89% 達·戴維森 $278→$106 評級下調 購買→中性
08/04/2022 303.6% 達·戴維森 $352→$278 維護
08/04/2022 117.77% 傑富瑞 $345→$150 評級下調 購買→Hold
06/02/2022 411.03% 達·戴維森 $341→$352 維護
02/24/2022 395.06% 達·戴維森 $349→$341 維護
11/08/2021 406.68% 達·戴維森 $395→$349 維護
05/05/2021 473.46% 達·戴維森 $302→$395 維護
02/26/2021 338.44% 達·戴維森 $239→$302 維護
2021/01/25 284.73% 傑富瑞 $205→$265 升級 持有→購買
2021/12/01 246.98% 達·戴維森 $205→$239 維護
11/05/2020 197.62% 達·戴維森 $180→$205 升級 中性→購買
06/25/2020 138.1% B.萊利證券 →$164 開始承保 →購買
05/06/2020 24.85% 達·戴維森 $83→$86 維護 中性
02/27/2020 20.5% 達·戴維森 $74→$83 維護 中性
2019年8月11日 7.43% 達·戴維森 $250→$74 評級下調 購買→中性
2019年07月25日 88.73% 傑富瑞 →$130 開始承保 →購買
2019年02月27日 213.59% 西多蒂公司 $211→$216 維護
2018/08/11 - 西多蒂公司 升級 中性→購買

What is the target price for Medifast (MED)?

Medifast(MED)的目標價格是多少?

The latest price target for Medifast (NYSE: MED) was reported by Stephens & Co. on October 13, 2023. The analyst firm set a price target for $82.00 expecting MED to rise to within 12 months (a possible 19.05% upside). 6 analyst firms have reported ratings in the last year.

史蒂芬斯公司於2023年10月13日公佈了Medifast(紐約證券交易所市場代碼:MED)的最新目標價。這家分析公司將目標價定為82.00美元,預計MED將在12個月內上漲(可能上漲19.05%)。6家分析公司在過去一年公佈了評級。

What is the most recent analyst rating for Medifast (MED)?

Medifast(MED)的最新分析師評級是多少?

The latest analyst rating for Medifast (NYSE: MED) was provided by Stephens & Co., and Medifast initiated their equal-weight rating.

對Medifast(紐約證券交易所市場代碼:MED)的最新分析師評級是由Stephens&Co.提供的,Medifast啟動了他們的同等權重評級。

When is the next analyst rating going to be posted or updated for Medifast (MED)?

Medifast(MED)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medifast, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medifast was filed on October 13, 2023 so you should expect the next rating to be made available sometime around October 13, 2024.

分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公開財務報表,與Medifast的高管和客戶交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Medifast的上一次評級是在2023年10月13日提交的,因此您應該預計下一次評級將在2024年10月13日左右提供。

Is the Analyst Rating Medifast (MED) correct?

分析師對Medifast(MED)的評級正確嗎?

While ratings are subjective and will change, the latest Medifast (MED) rating was a initiated with a price target of $0.00 to $82.00. The current price Medifast (MED) is trading at is $68.88, which is within the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的Medifast(MED)評級是以0.00美元至82.00美元的目標價啟動的。Medifast(MED)目前的交易價格為68.88美元,在分析師的預測範圍內。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論